SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-24-000062
Filing Date
2024-07-23
Accepted
2024-07-22 17:39:28
Documents
15
Period of Report
2024-07-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20240722.htm   iXBRL 8-K 29328
5 image_0.jpg GRAPHIC 28105
6 EX-5.1 slrx-ex51opiniontoprospect.htm EX-5.1 14888
  Complete submission text file 0001615219-24-000062.txt   212211

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20240722.xsd EX-101.SCH 1926
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20240722_lab.xml EX-101.LAB 22592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20240722_pre.xml EX-101.PRE 13078
17 EXTRACTED XBRL INSTANCE DOCUMENT flks-20240722_htm.xml XML 2724
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 241132432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)